About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Global Statistics
About the Journal
Types or Articles
About CAR T Cells
Frequently Asked Questions (FAQ)
The Review
Contact Us
Search
Latest News
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
News
November 10, 2025
Pediatric Oncology: Novel Treatment Proves ‘Miracle’ for 6-Year-Old with Leukemia
News
November 10, 2025
Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain Receive the 2025 Merkin Prize
News
November 5, 2025
Loma Linda University Health awarded $9 million from the California Institute for Regenerative Medicine
News
November 4, 2025
2025 Merkin Prize in Biomedical Technology awarded to pioneers of CAR T-cell therapy
News
October 29, 2025
First Follicular Lymphoma Patient Treated in CELESTIAL-301 Trial
News
October 2, 2025
Emily Whitehead Foundation to Expands its Mission Beyond Pediatric Cancer
News
September 30, 2025
Gabriele Casirati, MD receives the 2025 ASH Peter Steelman Scholar Award
News
September 15, 2025
Survey: Majority of Americans are Unaware of Groundbreaking Treatment option for Blood Cancer
News
April 17, 2025
Must Read
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
News
Loma Linda University Health awarded $9 million from the California Institute for Regenerative Medicine
The California Institute for Regenerative Medicine (CIRM) has awarded $9 million to Loma Linda University Health to create a Community Care Center of Excellence (CCCE) in...
Peter Hofland
-
November 4, 2025
Load more
Conference Coverage
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
Conference Coverage
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer
Peter Hofland
-
November 11, 2025
Conference Coverage
SITC 2025: Data Shows Promising Preclinical Results for SynKIR™-110 in Solid Tumors
Danielle Garcia
-
November 10, 2025
Load more
CAR T-Cell Therapy Updates
Updates
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
Business & Economics
‘Eureka Moment’ in Tumor Treatment: Nearly One in Five People Diagnosed with Cancer wiling to Choose an Innovative Therapy
Danielle Garcia
-
November 11, 2025
Conference Coverage
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer
Peter Hofland
-
November 11, 2025
News
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Results from the Phase 1 / 2a AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumors
Danielle Garcia
-
November 10, 2025
News
Pediatric Oncology: Novel Treatment Proves ‘Miracle’ for 6-Year-Old with Leukemia
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Data Shows Promising Preclinical Results for SynKIR™-110 in Solid Tumors
Danielle Garcia
-
November 10, 2025
Load more
Stay on Top - Get CAR T-Cell News in your inbox.
Sign Up for Our Newsletter Today!
Subscribe
Trending Updates
Business & Economics
‘Eureka Moment’ in Tumor Treatment: Nearly One in Five People Diagnosed with Cancer wiling to Choose an Innovative Therapy
Danielle Garcia
-
November 11, 2025
Conference Coverage
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer
Peter Hofland
-
November 11, 2025
News
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Results from the Phase 1 / 2a AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumors
Danielle Garcia
-
November 10, 2025
News
Pediatric Oncology: Novel Treatment Proves ‘Miracle’ for 6-Year-Old with Leukemia
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Data Shows Promising Preclinical Results for SynKIR™-110 in Solid Tumors
Danielle Garcia
-
November 10, 2025
Load more
Clinical Research
Clinical Trials
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
Clinical Trial Updates
CARsgen Announces Positive Clinical Data for Allogeneic CAR-T Products CT0596 and CT1190B
Danielle Garcia
-
November 3, 2025
Clinical Trial Updates
IASO Bio’s Anti-GPRC5D CAR T-Cell RD118 Shows Promising Results in Relapsed/Refractory Multiple Myeloma
Danielle Garcia
-
October 22, 2025
Clinical Trial Updates
Results of a First-in-Human Study Demonstrates Feasibility of In Vivo CAR T-Cell Therapy in Systemic Lupus Erythematosus
Danielle Garcia
-
September 17, 2025
Science Updates
Sciece & Discovery
All
ASCO
ASH
Business & Economics
Clinical Trial Updates
Conference Coverage
Contract Development an Manufacturing
News
Preclinical
Regulatory Updates
Science
More
Clinical Trial Updates
Results of a First-in-Human Study Demonstrates Feasibility of In Vivo CAR T-Cell Therapy in Systemic Lupus Erythematosus
Danielle Garcia
-
September 17, 2025
News
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
Peter Hofland
-
November 10, 2025
ASH
Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting
Danielle Garcia
-
November 3, 2025
Latest Articles
Business & Economics
‘Eureka Moment’ in Tumor Treatment: Nearly One in Five People Diagnosed with Cancer wiling to Choose an Innovative Therapy
Danielle Garcia
-
November 11, 2025
Conference Coverage
SITC 2025: Macrophage-targeting CAR monocytes Improve Immunotherapy Outcomes in Breast Cancer
Peter Hofland
-
November 11, 2025
News
Jiahui International Cancer Center Successfully Treats a 78-year-old Patient from New Zealand with Advanced CAR T-Cell Therapy
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Results from the Phase 1 / 2a AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumors
Danielle Garcia
-
November 10, 2025
News
Pediatric Oncology: Novel Treatment Proves ‘Miracle’ for 6-Year-Old with Leukemia
Peter Hofland
-
November 10, 2025
Conference Coverage
SITC 2025: Data Shows Promising Preclinical Results for SynKIR™-110 in Solid Tumors
Danielle Garcia
-
November 10, 2025
News
Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain Receive the 2025 Merkin Prize
Danielle Garcia
-
November 5, 2025
ASH
Verismo Therapeutics to Present Updated Study Results at SITC and ASH
Peter Hofland
-
November 5, 2025
Conference Coverage
SITC 2025: Parker Institute for Cancer Immunotherapy to Showcases Latest Advances in Immunotherapy
Danielle Garcia
-
November 5, 2025
News
Loma Linda University Health awarded $9 million from the California Institute for Regenerative Medicine
Peter Hofland
-
November 4, 2025
Business & Economics
Next-Generation Multiple Myeloma Therapies Market to Reach USD 37.07 Billion by 2033
Danielle Garcia
-
November 4, 2025
Preclinical
Grit Biotherapeutics to Deliver Oral Presentation at ASH 2025 on Breakthrough In Vivo CAR-T Therapy GT801
Danielle Garcia
-
November 4, 2025
1
2
3
4
Page 1 of 4